- Case report
- Open Access
Cutaneous granulomatosis and combined immunodeficiency revealing Ataxia-Telangiectasia: a case report
© Folgori et al; licensee BioMed Central Ltd. 2010
- Received: 25 February 2010
- Accepted: 11 April 2010
- Published: 11 April 2010
Ataxia-telangiectasia (A-T) is a complex multisystem disorder characterized by progressive neurological impairment, variable immunodeficiency and oculo-cutaneous telangiectasia. A-T is a member of chromosomal breakage syndromes and it is caused by a mutation in the ataxia-telangiectasia mutated (ATM) gene. Because of a wide clinical heterogeneity, A-T is often difficult to diagnose in children.
We report an unusual case of a 3-year-old boy affected by A-T who presented exclusively with extensive cutaneous granulomatosis and severe combined immunodeficiency, without neurological abnormalities, at the time of diagnosis. This case clearly emphasizes the variable presentation of A-T syndrome and highlights the difficulties in the early diagnosis of A-T.
A-T should be considered in children with evidence of combined humoral and cellular immunodeficiency associated with unexplained skin granulomatous lesions, even in the absence of the classic features of this syndrome.
- Chronic Granulomatous Disease
- Cerebellar Ataxia
- Severe Combine Immunodeficiency
- Common Variable Immunodeficiency
- Cellular Immunodeficiency
Ataxia-telangiectasia (A-T) is an autosomal recessive genomic instability syndrome characterized by progressive cerebellar ataxia, oculo-cutaneous telangiectasia, increased radiosensibility, predisposition to lymphoid malignancies and a variable degree of immunodeficiency. The prevalence is estimated to be between 1:100.000  and 1:40.000 . Both males and females are equally affected.
A-T results from mutations of a single gene, ATM (ataxia-telangiectasia mutated), located on chromosome 11q22-23 [3, 4], encoding a large basic protein involved in cell cycle control and DNA damaging repair.
The diagnosis of A-T is based primarily on clinical findings. Determination of serum alpha-fetoprotein (αFP) is an important diagnostic marker as raised αFP level is found in more than 90% of A-T patients. Confirmatory tests for A-T include colony radiosensitivity assay and identification of the ATM protein by immunoblotting [2, 5, 6].
We report the case of a 3-year-old boy affected by A-T who presented exclusively with extensive cutaneous granulomatousis and severe combined immunodeficiency, without neurological abnormalities.
A 3-year-old boy was referred to our Department of Pediatrics with a history of cutaneous lesions, recurrent otitis, repeated episodes of fever of unknown origin and suspected immunodeficiency. He was born full term as the second child of healthy non consanguineous parents.
Age matched controls
5-16 × 10 3
250-550 × 10 3
Serum immunoglobulin mg/dl
1.7-6.9 × 10 3
0.9-4.5 × 10 3
0.5-2.4 × 10 3
0.3-1.6 × 10 3
0.2-2.1 × 10 3
0.1-1 × 10 3
1.106 - 15.787
1.106 - 15.787
Response to mitogens and antigens (counts per minute)
Serological data after 3 vaccine doses
Tetanus toxoid IU/ml
Haemophilus influenzae B mg/l
S. Pneumoniae mg/l
Intravenous immunoglobulin infusion at the dosage of 400 mg/Kg monthly and prophylactic treatment with trimethoprim-sulfamethoxazole was started; during this period a marked reduction of EBV viral load was observed. Six months later the child experienced a bilateral acute otitis that required a long and multiple antibiotic therapy.
Based on the male-gender, hypogammaglobulinemia and high EBV replication rate, we firstly ruled out Lymphoproliferative X-linked Syndrome (XLP) and XIAP deficiency by molecular analysis . Schuetz et al. reported a hypomorphic heterozygous RAG mutation with skin granulomatous lesions associated with secondary complications of EBV infection and severe immunological abnormalities ; molecular analysis for RAG1/2 resulted negative. Even in the absence of a severe clinical picture, immunological B and T cells alterations led us to consider a leaky SCID. Sequencing of common γ-chain and IL7-R genes and dosage of ADA enzyme in white blood cells and plasma resulted normal. There was no evidence of maternal engraftment in the patient's peripheral blood by chimerism analysis.
In the suspect of a double strands break repair defect, radiosensitivity test was performed, showing an increased number of chromosomal aberrations. Alpha-fetoprotein (αFP) serum value repeatedly resulted increased (135 ng/ml, n.v. <10 ng/ml) and Western Blotting showed the absence of ATM protein.
Characterization of the ATM gene mutations are in progress.
Phenotypic heterogeneity has long been identified in both laboratory and clinical features of A-T, ranging from the classic form with typical symptoms to unusual disease presentation. Neurological involvement (i.e. cerebellar ataxia and dysarthria) and ocular telangectasia are the hallmarks of A-T. Nevertheless, milder forms of A-T, which are characterized by late onset or slow progression of neuromotor dysfunction, have been described and diagnosed even among adults during evaluation on unknown ataxia. The typical cutaneous manifestation of the disease is ocular telangectasia although some patients have no telangectasia, even in adulthood; cutaneous granulomatosis with no identifiable infectious origin occurs rarely in children with primary immunodeficiency [8–10]. These cutaneous granulomas have been previously described in common variable immunodeficiency [9, 11–13], chronic granulomatous disease, X-linked hypogammaglobulinemia [14, 15] but rarely in A-T [16–19]. Furthermore, we did not see resolution of granulomas after neither the local immunosuppressive therapy, nor the treatment with intravenous immunoglobulin, as it has been reported in some patients with common variable immunodeficiency [9, 20, 21].
Similarly to the phenotypic features, a wide variability of immunological defects exists in patients with A-T syndrome, ranging from the absence of immune defects to severe immunodeficiency with recurrent infections [22, 23]. Low levels of IgG, IgA and IgE are observed in more than 80% of the patients, whereas severe combined immunodeficiency with recurrent infections occur rarely. In our patient, immunological abnormalities were so severe that led us to suspect a combined immunodeficiency. Diagnosis led us to reveal A-T even in child's elder sister (8-years-old) for whom a wrong spastic paresis diagnosis was previously made elsewhere. She conversely presented a common clinical phenotype of A-T, showing progressive neurological degeneration with ataxia, dysarthria, dyskinesia, dystonia and oculo-cutaneous telangiectasia. Her immunological work-up only revealed a mild lymphopenia with an IgA defect. The different clinical picture seen in patients with defects of that same gene can be caused by specific mutations, other genetic factors or epigenetic mechanism. Previous studies have failed to indicate a specific correlation between the amount of ATM protein and radiosensitivity. However, the results of various studies suggest a clear correlation between preservation of neurological function, decreased radiosensitivity and level of normal ATM protein kinase activity. Interestingly, there are siblings, as our patients, who reported absent ATM protein but clinically and laboratory distinct phenotypes [23, 24]. Thus, our case supports the lack of a strict genotype-phenotype correlation[2, 22–26] suggesting that the heterogeneity of A-T is much broader than initially recognized and that A-T represents a complex spectrum of the disease shaped by the genetic mutations, host characteristics, pathogens (EBV) and environmental factors.
The prevalence of the disease reported in the literature is very variable and estimated to be 1:40,000-100,000 births [1, 2]; this is probably due to the wide clinical heterogeneity that often leads physicians to an incorrect or missed diagnosis. Atypical presentation of our patient caused a delay of diagnosis; there should be a high index of suspect for A-T among children with recurrent infections and immunodeficiency, even in the absence of neurological abnormalities. Accordingly, screening with serum alpha-fetoprotein, a simple, rapid and reliable test for A-T, should be part of the evaluation of children with any congenital immunodeficiency. A delayed diagnosis can often affect the clinical evolution and influence the management of A-T patients and their relatives [1, 27]. Early diagnosis alerts the physicians to limit ionizing radiations exposure, including the diagnostic methods. Also, early diagnosis allows genetic counseling as well as the identification of the carrier parents who may have an increased cancer risk, particularly breast cancer in women [1, 28].
In conclusion, A-T syndrome should be considered in children with an evidence of combined humoral and cellular immunodeficiency and otherwise unexplained granulomatous skin lesions.
Written informed consent was obtained from the patient's relatives for publication of this case report.
Prof. Paolo Rossi for critically review in the manuscript.
- Cabana MD, Crawford TO, Winkelstein JA, Christensen JR, Lederman HM: Consequences of the delayed diagnosis of ataxia-telangiectasia. Pediatrics. 1998, 102: 98-100.PubMedView ArticleGoogle Scholar
- Chun HH, Gatti RA: Ataxia-telangiectasia, an evolving phenotype. DNA Repair (Amst). 2004, 3 (8-9): 1187-96.View ArticleGoogle Scholar
- Lange E, Borresen AL, Chen X, Chessa L, Chiplunkar S, Concannon P, Dandekar S, Gerken S, Lange K, Liang T: Localization of an ataxia-telangiectasia gene to an approximately 500-kb interval on chromosome 11q23.1: linkage analysis of 176 families by an international consortium. Am J Hum Genet. 1995, 57 (1): 112-9.PubMed CentralPubMedGoogle Scholar
- Gatti RA, Berkel I, Boder E, Braedt G, Charmley P, Concannon P, Ersoy F, Foroud T, Jaspers NG, Lange K: Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. Nature. 1988, 336 (6199): 577-80.PubMedView ArticleGoogle Scholar
- Perlman S, Becker-Catania S, Gatti RA: Ataxia-telangiectasia: diagnosis and treatment. Semin Pediatr Neurol. 2003, 10 (3): 173-82.PubMedView ArticleGoogle Scholar
- Chun HH, Sun X, Nahas SA, Teraoka S, Lai CH, Concannon P, Gatti RA: Improved diagnostic testing for ataxia-telangiectasia by immunoblotting of nuclear lysates for ATM protein expression. Mol Genet Metab. 2003, 80 (4): 437-43.PubMedView ArticleGoogle Scholar
- Rigaud S, Fondanèche MC, Lambert N, Pasquier B, Mateo V, Soulas P, Galicier L, Le Deist F, Rieux-Laucat F, Revy P, Fischer A, de Saint Basile G, Latour S: XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature. 2006, 444 (7115): 110-4.PubMedView ArticleGoogle Scholar
- Schuetz C, Huck K, Gudowius S, Megahed M, Feyen O, Hubner B, Schneider DT, Manfras B, Pannicke U, Willemze R, Knüchel R, Göbel U, Schulz A, Borkhardt A, Friedrich W, Schwarz K, Niehues T: An immunodeficiency disease with RAG mutations and granulomas. N Engl J Med. 2008, 358 (19): 2030-8.PubMedView ArticleGoogle Scholar
- Mitra A, Pollock B, Gooi J, Darling JC, Boon A, Newton-Bishop JA: Cutaneous granulomas associated with primary immunodeficiency disorders. Br J Dermatol. 2005, 153 (1): 194-9.PubMedView ArticleGoogle Scholar
- Gallerani I, Innocenti DD, Coronella G, Berti S, Amato L, Moretti S, Fabbri P: Cutaneous sarcoid-like granulomas in a patient with X-linked hyper-IgM syndrome. Pediatr Dermatol. 2004, 21 (1): 39-43.PubMedView ArticleGoogle Scholar
- Lin JH, Liebhaber M, Roberts RL, Dyer Z, Stiehm ER: Etanercept treatment of cutaneous granulomas in common variable immunodeficiency. J Allergy Clin Immunol. 2006, 117 (4): 878-82.PubMedView ArticleGoogle Scholar
- Abdel-Naser MB, Wollina U, El Hefnawi MA, Habib MA, El Okby M: Non-sarcoidal, non-tuberculoid granuloma in common variable immunodeficiency. J Drugs Dermatol. 2006, 5 (4): 370-2.PubMedGoogle Scholar
- Malphettes M, Oksenhendler E, Galicier L, Fieschi C: Granulomatous disease in common variable immunodeficiency. Rev Med Interne. 2008, 29 (1): 28-32.PubMedView ArticleGoogle Scholar
- Vergnon JM, Guichenez P, Oriol P, Poulard G, Jaubert J, Emonot A: Acquired hypogammaglobulinemia and multifocal granulomatosis. Rev Mal Respir. 1993, 10 (5): 480-2.PubMedGoogle Scholar
- Fleming MG, Gewurz AT, Pearson RW: Caseating cutaneous granulomas in a patient with X-linked infantile hypogammaglobulinemia. J Am Acad Dermatol. 1991, 24 (4): 629-33.PubMedView ArticleGoogle Scholar
- Paller AS, Massey RB, Curtis MA, Pelachyk JM, Dombrowski HC, Leickly FE, Swift M: Cutaneous granulomatous lesions in patients with ataxia-telangiectasia. J Pediatr. 1991, 119 (6): 917-22.PubMedView ArticleGoogle Scholar
- Drolet BA, Drolet B, Zvulunov A, Jacobsen R, Troy J, Esterly NB: Cutaneous granulomas as a presenting sign in ataxia-telangiectasia. Dermatology. 1997, 194 (3): 273-5.PubMedView ArticleGoogle Scholar
- Joshi RK, al Asiri RH, Haleem A, Abanmi A, Patel CK: Cutaneous granuloma with ataxia telangiectasia--a case report and review of literature. Clin Exp Dermatol. 1993, 18 (5): 458-61.PubMedView ArticleGoogle Scholar
- Corbisier A, Eschard C, Motte J, Munzer M, Barhoum K, Kalis B, Grosshans E: Cutaneous granulomatous lesions disclosing ataxia-telangiectasia. Ann Dermatol Venereol. 1999, 126 (8-9): 608-11.PubMedGoogle Scholar
- Alvarez-Cuesta C, Molinos L, Cascante JA, Soler T, Pérez-Oliva N: Cutaneous granulomas in a patient with common variable immunodeficiency. Acta Derm Venereol. 1999, 79 (4): 334-PubMedView ArticleGoogle Scholar
- Cornejo P, Romero A, López S, Guerra A, Gil R, Iglesias L: Cutaneous and hepatic granulomas in a young woman with common variable immunodeficiency. Br J Dermatol. 1999, 140 (3): 546-7.PubMedView ArticleGoogle Scholar
- Claret Teruel G, Giner Muñoz MT, Plaza Martín AM, Martín Mateos MA, Piquer Gibert M, Sierra Martínez JI: Variability of immunodeficiency associated with ataxia telangiectasia and clinical evolution in 12 affected patients. Pediatr Allergy Immunol. 2005, 16 (7): 615-8.PubMedView ArticleGoogle Scholar
- Soresina A, Meini A, Lougaris V, Cattaneo G, Pellegrino S, Piane M, Darra F, Plebani A: Different clinical and immunological presentation of ataxia-telangiectasia within the same family. Neuropediatrics. 2008, 39 (1): 43-5.PubMedView ArticleGoogle Scholar
- Morio T, Takahashi N, Watanabe F, Honda F, Sato M, Takagi M, Imadome KI, Miyawaki T, Delia D, Nakamura K, Gatti RA, Mizutani S: Phenotypic variations between affected siblings with ataxia-telangiectasia: ataxia-telangiectasia in Japan. Int J Hematol. 2009, 90 (4): 455-62.PubMedView ArticleGoogle Scholar
- Becker-Catania SG, Chen G, Hwang MJ, Wang Z, Sun X, Sanal O, Bernatowska-Matuszkiewicz E, Chessa L, Lee EY, Gatti RA: Ataxia-telangiectasia: phenotype/genotype studies of ATM protein expression, mutations, and radiosensitivity. Mol Genet Metab. 2000, 70 (2): 122-33.PubMedView ArticleGoogle Scholar
- Gilad S, Chessa L, Khosravi R, Russell P, Galanty Y, Piane M, Gatti RA, Jorgensen TJ, Shiloh Y, Bar-Shira A: Genotype-phenotype relationships in ataxia-telangiectasia and variants. Am J Hum Genet. 1998, 62 (3): 551-61.PubMed CentralPubMedView ArticleGoogle Scholar
- Crawford TO, Skolasky RL, Fernandez R, Rosquist KJ, Lederman HM: Survival probability in ataxia telangiectasia. Arch Dis Child. 2006, 91 (7): 610-1.PubMed CentralPubMedView ArticleGoogle Scholar
- Swift M, Morrell D, Massey RB, Chase CL: Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med. 1991, 325 (26): 1831-6.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.